Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 143.50
-1.00 (-0.69%)
At close: Nov 12, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 64.02 billion as of November 12, 2026. It is the 14,322nd most valuable company in the world and the 11th biggest in Bangladesh. Its market cap has increased by 31.77% in one year.
Market Cap
64.02B
Enterprise Value
65.13B
Revenue
56.27B
Global Rank
Country Rank
#11 Bangladesh
PE Ratio
7.11
ChartMarket Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 64.02B, an increase of 3,250.08%. That is a compound annual growth rate of 13.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 64.02B | 40.55% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 194.40B |
| Renata | 49.07B |
| Unilever Consumer Care | 33.14B |
| Beacon Pharmaceuticals | 20.86B |
| The ACME Laboratories | 17.01B |
| Asiatic Laboratories | 12.56B |
| The IBN SINA Pharmaceutical Industry | 9.38B |
| Navana Pharmaceuticals | 6.97B |